Thread: Dimebon fails in clinical trials for alzheimer's
View Single Post
Old 03-03-2010, 01:42 PM
olsen's Avatar
olsen olsen is offline
Senior Member
  
Join Date: Aug 2006
Posts: 1,860
15 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,860
15 yr Member
Default Dimebon fails in clinical trials for alzheimer's
from the financial sector: news on Dimebon failure to meet clinical goals

Medivation, Inc. (NASDAQ:MDVN) shaded over 68% of its value and now trading at $12.85 after hitting a new 52-week low of $12.55 after the company's experimental drug Dimebon failed to meet the main goals in a late-stage clinical trial for Alzheimer's disease.
http://www.emailwire.com/release/352...VISN-MDVN.html
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here — it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote